written by reader Sarepta and dystrophin

by rnpowell | June 10, 2016 6:48 pm

The FDA has asked Sarepta to reveal results of muscle biopsies to see how much new dystrophin was made after treatment with eteplirsen, but haven’t they already said studies only showed 0.9% increase? Will this new release provide any new information and give hope to Sarepta investors, not to mention patients and families, or is it just a rehash of old data which will only give the FDA cover for disapproving the drug? RNP,MD

Source URL: https://sgumdev.stockgumshoe.com/2016/06/microblog-sarepta-and-dystrophin/



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments